2926 related articles for article (PubMed ID: 15667859)
21. Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study.
Werner M; Schmid DM; Schüssler B
Am J Obstet Gynecol; 2005 May; 192(5):1735-40. PubMed ID: 15902187
[TBL] [Abstract][Full Text] [Related]
22. Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients.
Mascarenhas F; Cocuzza M; Gomes CM; Leão N
Neurourol Urodyn; 2008; 27(4):311-4. PubMed ID: 17914742
[TBL] [Abstract][Full Text] [Related]
23. Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions.
Klaphajone J; Kitisomprayoonkul W; Sriplakit S
Arch Phys Med Rehabil; 2005 Nov; 86(11):2114-8. PubMed ID: 16271557
[TBL] [Abstract][Full Text] [Related]
24. Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity?
Kuo HC
Urology; 2006 Nov; 68(5):993-7; discussion 997-8. PubMed ID: 17113890
[TBL] [Abstract][Full Text] [Related]
25. Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?
Sahai A; Sangster P; Kalsi V; Khan MS; Fowler CJ; Dasgupta P
BJU Int; 2009 Mar; 103(5):630-4. PubMed ID: 18990156
[TBL] [Abstract][Full Text] [Related]
26. Satisfaction with urethral injection of botulinum toxin A for detrusor sphincter dyssynergia in patients with spinal cord lesion.
Kuo HC
Neurourol Urodyn; 2008; 27(8):793-6. PubMed ID: 18508331
[TBL] [Abstract][Full Text] [Related]
27. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
Grosse J; Kramer G; Jakse G
BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
[TBL] [Abstract][Full Text] [Related]
28. The effect of botulinum toxin type a on overactive bladder symptoms in patients with multiple sclerosis: a pilot study.
Mehnert U; Birzele J; Reuter K; Schurch B
J Urol; 2010 Sep; 184(3):1011-6. PubMed ID: 20643431
[TBL] [Abstract][Full Text] [Related]
29. [Botulinum A toxin in the treatment of patients with detrusor external sphincter dyssynergia and neurogenic low detrusor contractility].
Mazo EB; Krivoborodov GG; Efremov NS
Ter Arkh; 2008; 80(10):49-52. PubMed ID: 19105415
[TBL] [Abstract][Full Text] [Related]
30. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
Giannantoni A; Mearini E; Del Zingaro M; Porena M
Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
[TBL] [Abstract][Full Text] [Related]
31. Concomitant repeated intravesical injections of botulinum toxin-type A and laparoscopic antegrade continence enema; a new solution for an old problem.
Kajbafzadeh A; Mahboubi AH; Payabvash S
BJU Int; 2009 May; 103(9):1248-54. PubMed ID: 19154454
[TBL] [Abstract][Full Text] [Related]
32. Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction.
Kuo HC
J Urol; 2003 Nov; 170(5):1908-12. PubMed ID: 14532805
[TBL] [Abstract][Full Text] [Related]
33. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
Sahai A; Dowson C; Khan MS; Dasgupta P
BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
[TBL] [Abstract][Full Text] [Related]
34. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.
Akbar M; Abel R; Seyler TM; Bedke J; Haferkamp A; Gerner HJ; Möhring K
BJU Int; 2007 Sep; 100(3):639-45. PubMed ID: 17532858
[TBL] [Abstract][Full Text] [Related]
35. [Subjective patient satisfaction after injection of botulinum-a toxin in detrusor overactivity].
Schulte-Baukloh H; Weiss C; Schobert J; Stolze T; Stürzebecher B; Knispel HH
Aktuelle Urol; 2005 Jun; 36(3):230-3. PubMed ID: 16001338
[TBL] [Abstract][Full Text] [Related]
36. The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor.
Hoebeke P; De Caestecker K; Vande Walle J; Dehoorne J; Raes A; Verleyen P; Van Laecke E
J Urol; 2006 Jul; 176(1):328-30; discussion 330-1. PubMed ID: 16753434
[TBL] [Abstract][Full Text] [Related]
37. Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder.
Mokhless I; Gaafar S; Fouda K; Shafik M; Assem A
J Urol; 2006 Oct; 176(4 Pt 2):1767-70; discussion 1770. PubMed ID: 16945643
[TBL] [Abstract][Full Text] [Related]
38. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study.
Giannantoni A; Costantini E; Di Stasi SM; Tascini MC; Bini V; Porena M
Eur Urol; 2006 Apr; 49(4):704-9. PubMed ID: 16417964
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity.
Jeffery S; Fynes M; Lee F; Wang K; Williams L; Morley R
BJU Int; 2007 Dec; 100(6):1302-6. PubMed ID: 17979928
[TBL] [Abstract][Full Text] [Related]
40. A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity.
Rajkumar GN; Small DR; Mustafa AW; Conn G
BJU Int; 2005 Oct; 96(6):848-52. PubMed ID: 16153215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
